LumiEsoステント食道システム

生体適合性材料で設計されたこの高度なステントシステムは、以下を提供する。 効果的なサポート にとって 食道狭窄持続的な 管腔開存率 改善された 嚥下機能 患者における 食道閉塞.

LumiEsoステント食道システム革新的, 自己拡張型 stent solution engineered to reestablish そして maintain esophageal patency in patients with malignant または benign strictures. Crafted with 高度 nitinol or hybrid alloys and featuring precision deployment mechanics, LumiEso stents foster 信頼できる decompression under endoscopic または fluoroscopic guidance—promoting 改良型 ingestion, quality of life, and reduced procedure times in everyday clinical practice.

主な特徴とテクノロジー

High-Radial-Force Stent Construction
  • Durable Nitinol/Hybrid Alloy: Supplies 継続的 radial expansion to support stenotic segments, resisting the dynamic pressures of esophageal peristalsis.
  • Flexible Architecture: Conforms to the esophagus’ curvature, reducing patient discomfort and risk of stent migration.
  • Low-Profile System: Designed for smooth passage through narrow strictures.
  • Gradual Unveiling Mechanism: Offers careful positioning, minimizing the risk of misplacement and enabling partial recapture if a reposition is necessary (model-specific).
  • Enhanced Imaging: Distinct markers at the stent’s proximal and distal ends ensure exact alignment with the stricture edges.
  • Real-Time Visualization: Under endoscopic or fluoroscopic guidance, these markers help operators confirm final stent coverage.
  • Flared Ends or Anchoring Loops: Stabilize the stent in high motility sections of the esophagus, mitigating the risk of distal or proximal migration.
  • Coatings (some models): May include polyurethane or silicone coatings to inhibit tumor ingrowth and maintain a smooth inner lumen.
  • Durable Nitinol/Hybrid Alloy: Supplies 継続的 radial expansion to support stenotic segments, resisting the dynamic pressures of esophageal peristalsis.
  • Flexible Architecture: Conforms to the esophagus’ curvature, reducing patient discomfort and risk of stent migration.
  • Low-Profile System: Designed for smooth passage through narrow strictures.
  • Gradual Unveiling Mechanism: Offers careful positioning, minimizing the risk of misplacement and enabling partial recapture if a reposition is necessary (model-specific).
  • Enhanced Imaging: Distinct markers at the stent’s proximal and distal ends ensure exact alignment with the stricture edges.
  • Real-Time Visualization: Under endoscopic or fluoroscopic guidance, these markers help operators confirm final stent coverage.
  • Flared Ends or Anchoring Loops: Stabilize the stent in high motility sections of the esophagus, mitigating the risk of distal or proximal migration.
  • Coatings (some models): May include polyurethane or silicone coatings to inhibit tumor ingrowth and maintain a smooth inner lumen.

Clinical Applications & Benefits

Malignant & Benign Strictures
  • Esophageal Cancer or External Compression: palliative relief of dysphagia, enhancing nutritional intake and patient comfort.
  • Benign Conditions: e.g., peptic strictures, anastomotic strictures—temporary stenting can allow tissue healing or bridging until further therapy.
  • Endoscopic or Fluoroscopic Placement: Reduces morbidity compared to open surgical bypass, accelerating recovery and minimizing hospital stay.
  • Immediate Symptom Relief: Restores esophageal lumen patency, alleviating dysphagia and allowing better hydration/nutrition.
  • Robust Radial Force: Ensures the stent consistently dilates the stricture, often decreasing repeated procedures for stent blockage or displacement.
  • Tissue-Sparing: Avoids large incisions or extensive tissue resection, preserving esophageal function as feasible.
  • Enhanced Oral Intake: Patients may resume more normal diets shortly after stent insertion.
  • Palliative & Bridge-to-Surgery: With malignant pathologies, stenting extends comfortable life expectancy; for others, it supports a phased approach to eventual definitive therapy.
  • Esophageal Cancer or External Compression: palliative relief of dysphagia, enhancing nutritional intake and patient comfort.
  • Benign Conditions: e.g., peptic strictures, anastomotic strictures—temporary stenting can allow tissue healing or bridging until further therapy.
  • Endoscopic or Fluoroscopic Placement: Reduces morbidity compared to open surgical bypass, accelerating recovery and minimizing hospital stay.
  • Immediate Symptom Relief: Restores esophageal lumen patency, alleviating dysphagia and allowing better hydration/nutrition.
  • Robust Radial Force: Ensures the stent consistently dilates the stricture, often decreasing repeated procedures for stent blockage or displacement.
  • Tissue-Sparing: Avoids large incisions or extensive tissue resection, preserving esophageal function as feasible.
  • Enhanced Oral Intake: Patients may resume more normal diets shortly after stent insertion.
  • Palliative & Bridge-to-Surgery: With malignant pathologies, stenting extends comfortable life expectancy; for others, it supports a phased approach to eventual definitive therapy.